The specific blood product used for replacement of clotting factors and fibrinogen is:
a. whole blood.
b. packed RBCs.
c. cryoprecipitate.
d. albumin, 25% pooled.
C
Cryoprecipitate replaces factors VIII and XIII, von Willebrand's factor, and fibrinogen. It also replaces red cell mass and plasma volume and is expected to raise hemoglobin by 1 g/100 mL and hematocrit by 3% in a nonhemorrhaging adult. Using cryoprecipitate is the preferred method of replacing red blood cell mass.
You might also like to view...
The nurse is meeting a patient for the first time. The initial step when initiating a nurse-patient relationship is for the nurse to:
a. appear interested. b. introduce her/himself. c. provide support. d. communicate trust.
A patient who is due for a dose of an otic antibiotic is noted to have exudate and cerumen par-tially obstructing the external auditory canal. How should the health care provider administer the drug?
a. Warm the solution before use. b. Chill the solution before use. c. Remove the debris using warm water irrigation before instillation. d. Put a moist facecloth over the ear for 10 minutes after instillation.
Woodward suggests there is a new emphasis on a change of consciousness, a focused intentionality toward caring and healing relationships and modalities, a shift toward a spiritualization of health as opposed to a limited medicalized view
Indicate whether this statement is true or false.
Passive immunity is provided by
a. transfer of preformed human antibodies. b. injection of human immune globulin. c. injection with preformed animal antibodies. d. vaccines with dead or altered organisms. e. active